Clinical Trials Logo

Clinical Trial Summary

This clinical trial evaluates the impact of synthetic cooling agents in combustible cigarettes on smoking perceptions and use. Menthol, a natural chemical, is a cooling agent that increases nicotine dependence among smokers. Menthol cigarettes largely contribute to the huge burden that smoking puts on public health. Approximately 43% of adult smokers smoke menthol cigarettes. Regulatory agencies have begun a ban on menthol. In response to the ban, the tobacco industry has introduced synthetic cooling agents as a flavorless replacement to provide the same cooling effects as menthol. Information gained from this trial may help researchers determine how the addition of synthetic cooling agents changes the appeal, abuse liability potential, and respiratory toxicity profile of combustible cigarettes.


Clinical Trial Description

PRIMARY OBJECTIVES: I. Assess the content of synthetic cooling agents in newly introduced cooling agent non-menthol, menthol, and traditional non-menthol cigarettes. II. Assess the subjective effects and abuse liability of cooling agent non-menthol cigarettes. EXPLORATORY OBJECTIVE: I. Examine acute changes to pulmonary health associated with cooling agent cigarette use. OUTLINE: Participants are randomized to use 1 of 3 cigarette conditions at 3 different study visits. Participants participate in ad libitum smoking sessions with either a non-menthol control, menthol, or synthetic cooling agent cigarette condition once weekly (QW) over 3 weeks on study. Participants also participate in an ad libitum smoking session with either their usual brand cigarette or the study cigarette condition at the end of each study visit. Participants also undergo nasal swab collection over 5-10 minutes and spirometry and airwave oscillometry testing over 5-10 minutes pre- and post-smoking session at each study visit. ;


Study Design


Related Conditions & MeSH terms

  • Cigarette Smoking-Related Carcinoma

NCT number NCT06230159
Study type Interventional
Source Ohio State University Comprehensive Cancer Center
Contact The Ohio State Comprehensive Cancer Center
Phone 800-293-5066
Email OSUCCCClinicaltrials@osumc.edu
Status Recruiting
Phase N/A
Start date November 28, 2023
Completion date December 31, 2025

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06038526 - Evaluation of Canakinumab in High-Risk Former-Smokers Phase 2
Recruiting NCT05121051 - Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers Phase 2
Not yet recruiting NCT06386432 - EQQUAL-NM for the Promotion of Smoking Cessation in Sexual and Gender Minority Young Adults in New Mexico N/A
Active, not recruiting NCT02964182 - Very Low Nicotine Content Cigarettes and E-Cigarettes in Promoting Smoking Cessation in Daily and Intermittent Cigarette Smokers N/A
Completed NCT04510077 - SmartQuit Program for Smoking Cessation N/A
Completed NCT04525222 - mHealth Mood Management Tool (Actify) to Improve Population-Level Smoking Cessation Phase 1
Recruiting NCT05825001 - Evaluating the Episodic Future Thinking Intervention for Reducing Cigarette Consumption in Cigarette Smokers N/A
Completed NCT05455086 - Free-Base Nicotine or Nicotine Salt e-Liquids in Current E-Cigarette Smokers, PeloPET Study N/A
Recruiting NCT06010355 - Culturally Tailored Educational Video to Promote Lung Cancer Screening in Vulnerable Communities N/A
Active, not recruiting NCT05236894 - Appeal of Nicotine Pouches Versus Cigarettes in the Ohio Appalachia Population Early Phase 1
Not yet recruiting NCT06213532 - CONNECTing to LungCare N/A
Recruiting NCT03856515 - Gender Differences in Switching From Smoking Regular Cigarettes to E-Cigarettes N/A
Completed NCT03480373 - Electronic Cigarette Use During Pregnancy
Not yet recruiting NCT06055231 - PK/PD of Vaping THC-containing Liquids vs. Smoked Cannabis Phase 1
Not yet recruiting NCT06145763 - A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking N/A
Active, not recruiting NCT04308759 - An Innovative Conversational Agent (Quitbot) for Smoking Cessation Phase 3
Active, not recruiting NCT04972513 - Impact of E-cigarette Use on the Body
Withdrawn NCT05024955 - Evaluating Shared Decision-Making for Lung Cancer Screening Among Chinese Populations in the United States
Completed NCT05227027 - Pilot Trial of a Game Embedded in a Smartphone App for Smoking Cessation N/A
Completed NCT04502524 - Website Smoking Cessation Intervention for the Promotion of Smoking Cessation in Low-Income Veterans Phase 1